Gene Therapy
Optimize your gene therapy workflows
Gene editing technologies have shown to optimize functional genomics, genetic screening, target identification and nucleotide payload development to elevate gene therapy research.
Optimize your gene therapy workflows
Gene editing technologies have shown to optimize functional genomics, genetic screening, target identification and nucleotide payload development to elevate gene therapy research.
In vivo gene editing uses a delivery vehicle such as a virus, for example an adeno-associated virus (AAV), or a non-viral nanoparticle which can target the gene of interest to the disease-associated tissue or organ.
We offer enablement and transformative solutions for your gene therapy discovery, development, and manufacturing processes:
- Improve your CRISPR gene editing workflows
- Design and characterize your delivery vector and payload cassette
- Monitor the safety and efficacy of the biotherapeutic
- Evaluate and document your Critical Quality Attributes (CQAs)
Cell Therapy
Elevate your cell therapy programs
Depending on availability, immunocompatibility, and sample source, cell-based therapies can be segmented into two categories: autologous and allogenic.
Elevate your cell therapy programs
Depending on availability, immunocompatibility, and sample source, cell-based therapies can be segmented into two categories: autologous and allogenic.
Autologous therapies are customized to an individual’s needs, in which cells are enriched, modified, and injected back into the same individual to elicit a desired immunotherapeutic response.
In allogeneic cell-based therapies, cells or tissue (e.g., bone marrow, adipose fat) from unrelated donors are banked in large batches using Good Manufacturing Practices (GMP) to treat larger populations.
We offer enablement and transformative cellular therapy products for your discovery, development, and scale up processes:
- Accurately count and characterize both subject or donor-derived cells
- Enrich, expand, and engineer your desired cells for CAR-T programs
- Establish well-defined immunoassay protocols to measure cell signaling and protein binding activity
- Evaluate and document your Critical Quality Attributes (CQAs)
Leverage our expertise
Explore our cell and gene therapy solutions
Questions?
We’re here to help.
Contact us Please note that product labeling (such as kit insert, product label, and kit box) may be different compared to the company branding. Please contact your local representative for further details.